Stryker to Buy Spine Technology From VertiFlex
The minimally invasive spine device maker aims to use funds from the sale to advance its platform for spinal stenosis treatments, according to the release. The scale and scope of the deal are not disclosed, and will include cash and contingent payments as well as a long-term licensing agreement.
VertiFlex is currently conducting an investigational device exemption trial for its Superion Interspinous Spacer system.
More Articles on Supply Chain:
41 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in February
Dr. Stephen Cook Named to Precision Spine Board of Directors
Nexxt Spine Consolidates, Relocates Headquarters
© Copyright ASC COMMUNICATIONS 2015. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.